Exclusivity Information
Synovex Plus Synovex Choice Synovex Primer holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2027. Details of Synovex Plus Synovex Choice Synovex Primer's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Apr 05, 2027 |
About Synovex Plus Synovex Choice Synovex Primer
Synovex Plus Synovex Choice Synovex Primer is a drug
owned by ZOETIS INC.
Synovex Plus Synovex Choice Synovex Primer uses
Estradiol Benzoate, Trenbolone Acetate as the active
ingredients.
Active Ingredient:
Synovex Plus Synovex Choice Synovex Primer uses
Estradiol Benzoate,
Trenbolone Acetate
as the active ingredients.
Check out other Drugs and Companies using
Estradiol Benzoate, Trenbolone Acetate ingredient.